Benefits
Sulfite Metabolism Support
Molybdenum is the cofactor for sulfite oxidase, which converts sulfite to sulfate. Supplying molybdenum, including as the glycinate chelate, helps ensure this enzyme has the cofactor needed to support normal handling of sulfites and sulfur-containing foods.
Molybdenum Cofactor Support
Like other molybdenum sources, the glycinate form provides molybdenum used to build the molybdenum cofactor required by sulfite oxidase, xanthine oxidase, and aldehyde oxidase, helping maintain the normal activity of these enzymes.
Gentle, Clean-Label Option
Amino-acid-chelated minerals are often chosen for sensitive users and clean-label formulas. Molybdenum glycinate offers a way to supply this trace mineral in a chelated form, though comfort and absorbability advantages over soluble salts are not established in human data.
Maintains Adequate Molybdenum Status
For people with low dietary molybdenum intake, the glycinate chelate provides elemental molybdenum that helps maintain adequate status of this essential trace mineral and the broad set of enzymes that depend on its cofactor.
Mechanism of action
Molybdenum Cofactor Formation
Molybdenum released from the glycinate chelate is built into the pterin-based molybdenum cofactor, the prosthetic group that activates human molybdenum-dependent enzymes and determines their maximal activity.
Sulfite Oxidase Activation
The molybdenum cofactor enables sulfite oxidase to oxidize sulfite to sulfate, a step essential for safe metabolism of sulfur amino acids and the molybdenum function most clearly important to human health.
Amino-Acid Chelate Delivery
In chelate form, molybdenum is coordinated to glycine, which is proposed to aid mineral handling in the gut. For molybdenum, however, soluble forms are already efficiently absorbed, so any added benefit of chelation is theoretical.
Urinary-Regulated Homeostasis
Regardless of source, absorbed molybdenum is regulated mainly by urinary excretion, which buffers the body against shortfall and excess and keeps molybdenum-cofactor supply within a stable range.
Clinical trials
Scoping review of human molybdenum nutrition prepared for dietary-reference work, summarizing absorption, status markers, and the comparative evidence (or lack thereof) among molybdenum forms.
Evidence synthesis of human molybdenum studies.
The review concludes that water-soluble molybdate is efficiently absorbed, that there are no validated biochemical markers of molybdenum status, and that clinical molybdenum deficiency does not occur in otherwise healthy people. It provides no evidence that chelated molybdenum is better absorbed than soluble salts.
Controlled metabolic study using stable molybdenum isotopes in young men across low and high intakes, measuring absorption, urinary excretion, and retention during depletion and repletion.
Healthy young men in a metabolic ward.
Soluble molybdenum was already efficiently absorbed across a wide range of intakes, with the body regulating status through urinary excretion. Because soluble molybdenum absorption is high, the data give no basis for expecting a meaningful absorption advantage from amino-acid chelation.